Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Suc

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Acta Neurochirurgica|January 1, 1989
Curability of third ventricular region tumours. A multidisciplinary approach to evaluate the places of operative, radiation and chemotherapyE Suc, A Pons, H Roche, et al.
The Journal of Urology|March 1, 1989
Stage IE nonHodgkin's lymphoma of the testis: a need for a brief aggressive chemotherapyH Roche, E Suc, A Pons, et al.
Acta Neurochirurgica|January 1, 1990
Brain tumours under the age of three. The price of survival. A retrospective study of 20 long-term survivorsE Suc, C Kalifa, R Brauner, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1992
[Multiple localization and lymphatic involvement of papillary micro-carcinoma of the thyroid. Results of total thyroidectomy with bilateral lymph node excision. Apropos of 38 patients]J M David, C Ruaux, J M Bachaud, et al.
Pediatric Hematology and Oncology|January 1, 1989
Immunohistochemical detection of post-therapy residual testicular lymphoblasts in childhood acute lymphoblastic leukemia (ALL)E Suc, A Robert, H Rubie, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility studyY Merrouche, J M Extra, D Abigerges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Phase II study of vinorelbine in patients with androgen-independent prostate cancerS Oudard, A Caty, Y Humblet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapyP Rougier, R Bugat, J Y Douillard, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Neurochirurgica|January 1, 1989
Curability of third ventricular region tumours. A multidisciplinary approach to evaluate the places of operative, radiation and chemotherapyE Suc, A Pons, H Roche, et al.
The Journal of Urology|March 1, 1989
Stage IE nonHodgkin's lymphoma of the testis: a need for a brief aggressive chemotherapyH Roche, E Suc, A Pons, et al.
Acta Neurochirurgica|January 1, 1990
Brain tumours under the age of three. The price of survival. A retrospective study of 20 long-term survivorsE Suc, C Kalifa, R Brauner, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|January 1, 1992
[Multiple localization and lymphatic involvement of papillary micro-carcinoma of the thyroid. Results of total thyroidectomy with bilateral lymph node excision. Apropos of 38 patients]J M David, C Ruaux, J M Bachaud, et al.
Pediatric Hematology and Oncology|January 1, 1989
Immunohistochemical detection of post-therapy residual testicular lymphoblasts in childhood acute lymphoblastic leukemia (ALL)E Suc, A Robert, H Rubie, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility studyY Merrouche, J M Extra, D Abigerges, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Phase II study of vinorelbine in patients with androgen-independent prostate cancerS Oudard, A Caty, Y Humblet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapyP Rougier, R Bugat, J Y Douillard, et al.
Pageof 1